Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshio Shimizu

Showing results (81-90 of 219) with videos related to

Pageof 22
Sort By:
Neuropathology : Official Journal of the Japanese Society of Neuropathology|April 20, 2016
A Japanese familial ALS patient with autonomic failure and a p.Cys146Arg mutation in the gene for SOD1 (SOD1)Kentaro Hayashi, Yoko Mochizuki, Reiji Koide, et al.
Cancer Chemotherapy and Pharmacology|July 9, 2020
Phase I safety and pharmacokinetic study of YM155, a potent selective survivin inhibitor, in combination with erlotinib in patients with EGFR TKI refractory advanced non-small cell lung cancerToshio Shimizu, Kazuto Nishio, Kazuko Sakai, et al.
Rinsho Shinkeigaku = Clinical Neurology|March 9, 2013
[Communication disorder in amyotrophic lateral sclerosis after ventilation--a proposal of staging and a study of predictive factor]Kentaro Hayashi, Yoko Mochizuki, Yuki Nakayama, et al.
Muscle & Nerve|February 1, 2008
Dissociated small hand muscle atrophy in amyotrophic lateral sclerosis: frequency, extent, and specificitySatoshi Kuwabara, Masahiro Sonoo, Tetsuo Komori, et al.
Respirology Case Reports|September 2, 2024
Unsuccessful rechallenge with nivolumab in a patient with advanced non-small cell lung cancer who had a 6-year complete response and treatment-free period: Case reportToshiaki Takakura, Hiroaki Akamatsu, Atsushi Washioka, et al.
Annals of Clinical and Translational Neurology|May 15, 2026
Sex-Stratified Association of Regional Dopamine Transporter Binding With Disease Progression in Amyotrophic Lateral SclerosisTomoya Kawazoe, Keizo Sugaya, Kentaro Hayashi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 30, 2023
Clinical relevance of macroglossia to disease progression in ventilation dependent patients with advanced ALSChiharu Matsuda, Toshio Shimizu, Yuki Nakayama, et al.
Frontiers in Oncology|May 7, 2019
Impact of Hepatitis Virus on the Feasibility and Efficacy of Anticancer Agents in Patients With Hepatocellular Carcinoma in Phase I Clinical TrialsTakafumi Koyama, Shunsuke Kondo, Toshio Shimizu, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 20, 2019
Progressive deterioration of sensory cortex excitability in advanced amyotrophic lateral sclerosis with invasive ventilationToshio Shimizu, Yuki Nakayama, Asuka Funai, et al.
Muscle & Nerve|May 12, 2026
Offset Conduction Velocity Reveals Prognostic Slowing of Motor Axons in Amyotrophic Lateral SclerosisToshio Shimizu, Hironobu Myojin, Kota Bokuda, et al.
Pageof 22

Showing results (81-90 of 219) with videos related to

Sort By:
Pageof 22
Neuropathology : Official Journal of the Japanese Society of Neuropathology|April 20, 2016
A Japanese familial ALS patient with autonomic failure and a p.Cys146Arg mutation in the gene for SOD1 (SOD1)Kentaro Hayashi, Yoko Mochizuki, Reiji Koide, et al.
Cancer Chemotherapy and Pharmacology|July 9, 2020
Phase I safety and pharmacokinetic study of YM155, a potent selective survivin inhibitor, in combination with erlotinib in patients with EGFR TKI refractory advanced non-small cell lung cancerToshio Shimizu, Kazuto Nishio, Kazuko Sakai, et al.
Rinsho Shinkeigaku = Clinical Neurology|March 9, 2013
[Communication disorder in amyotrophic lateral sclerosis after ventilation--a proposal of staging and a study of predictive factor]Kentaro Hayashi, Yoko Mochizuki, Yuki Nakayama, et al.
Muscle & Nerve|February 1, 2008
Dissociated small hand muscle atrophy in amyotrophic lateral sclerosis: frequency, extent, and specificitySatoshi Kuwabara, Masahiro Sonoo, Tetsuo Komori, et al.
Respirology Case Reports|September 2, 2024
Unsuccessful rechallenge with nivolumab in a patient with advanced non-small cell lung cancer who had a 6-year complete response and treatment-free period: Case reportToshiaki Takakura, Hiroaki Akamatsu, Atsushi Washioka, et al.
Annals of Clinical and Translational Neurology|May 15, 2026
Sex-Stratified Association of Regional Dopamine Transporter Binding With Disease Progression in Amyotrophic Lateral SclerosisTomoya Kawazoe, Keizo Sugaya, Kentaro Hayashi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 30, 2023
Clinical relevance of macroglossia to disease progression in ventilation dependent patients with advanced ALSChiharu Matsuda, Toshio Shimizu, Yuki Nakayama, et al.
Frontiers in Oncology|May 7, 2019
Impact of Hepatitis Virus on the Feasibility and Efficacy of Anticancer Agents in Patients With Hepatocellular Carcinoma in Phase I Clinical TrialsTakafumi Koyama, Shunsuke Kondo, Toshio Shimizu, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 20, 2019
Progressive deterioration of sensory cortex excitability in advanced amyotrophic lateral sclerosis with invasive ventilationToshio Shimizu, Yuki Nakayama, Asuka Funai, et al.
Muscle & Nerve|May 12, 2026
Offset Conduction Velocity Reveals Prognostic Slowing of Motor Axons in Amyotrophic Lateral SclerosisToshio Shimizu, Hironobu Myojin, Kota Bokuda, et al.
Pageof 22